CBLL logo

CeriBell, Inc. Stock Price

NasdaqGS:CBLL Community·US$629.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

CBLL Share Price Performance

US$16.66
-11.36 (-40.54%)
US$16.66
-11.36 (-40.54%)
Price US$16.66

CBLL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with limited growth.

1 Risk
2 Rewards

CeriBell, Inc. Key Details

US$82.8m

Revenue

US$9.9m

Cost of Revenue

US$72.9m

Gross Profit

US$125.3m

Other Expenses

-US$52.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-1.41
87.99%
-63.35%
12.0%
View Full Analysis

About CBLL

Founded
2014
Employees
281
CEO
Xingjuan Chao
WebsiteView website
www.ceribell.com

CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Recent CBLL News & Updates

Recent updates

No updates